• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Hotspots for mutations in the SARS-CoV-2 spike glycoprotein: a correspondence analysis

tetano

Editor, Senior Moderator
Sci Rep


. 2021 Dec 8;11(1):23622.
doi: 10.1038/s41598-021-01655-y.
Hotspots for mutations in the SARS-CoV-2 spike glycoprotein: a correspondence analysis


Mohammad Reza Rahbar[SUP] 1 [/SUP], Abolfazl Jahangiri[SUP] 2 [/SUP], Saeed Khalili[SUP] 3 [/SUP], Mahboubeh Zarei[SUP] 1 [/SUP], Kamran Mehrabani-Zeinabad[SUP] 4 [/SUP], Bahman Khalesi[SUP] 5 [/SUP], Navid Pourzardosht[SUP] 6 7 [/SUP], Anahita Hessami[SUP] 8 [/SUP], Navid Nezafat[SUP] 1 [/SUP], Saman Sadraei[SUP] 1 [/SUP], Manica Negahdaripour[SUP] 9 10 [/SUP]



Affiliations

Abstract

Spike glycoprotein (Sgp) is liable for binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to the host receptors. Since Sgp is the main target for vaccine and drug designing, elucidating its mutation pattern could help in this regard. This study is aimed at investigating the correspondence of specific residues to the Sgp[SUB]SARS-CoV-2[/SUB] functionality by explorative interpretation of sequence alignments. Centrality analysis of the Sgp dissects the importance of these residues in the interaction network of the RBD-ACE2 (receptor-binding domain) complex and furin cleavage site. Correspondence of RBD to threonine500 and asparagine501 and furin cleavage site to glutamine675, glutamine677, threonine678, and alanine684 was observed; all residues are exactly located at the interaction interfaces. The harmonious location of residues dictates the RBD binding property and the flexibility, hydrophobicity, and accessibility of the furin cleavage site. These species-specific residues can be assumed as real targets of evolution, while other substitutions tend to support them. Moreover, all these residues are parts of experimentally identified epitopes. Therefore, their substitution may affect vaccine efficacy. Higher rate of RBD maintenance than furin cleavage site was predicted. The accumulation of substitutions reinforces the probability of the multi-host circulation of the virus and emphasizes the enduring evolutionary events.
 
Back
Top Bottom